For the 2nd quarter ending 30 September 2017, the Group registered revenues of RM7.959 million, an increase of RM6.872 million or 632.2% as compared to RM1.087 million in the previous year's corresponding quarter. Profit before tax improved by RM19.280 million or 1,069.3% to RM21.083 million and net profit attributable to equity holders increased by RM18.947 million or 1,048.0% to RM20.755 as compared to the previous year's corresponding quarter of RM1.808million. The higher profit recorded was mainly due to the marking to market of our medium to long term investments of approximately RM19.053 million.
I like the way Asiabio keeping the shape this way. Let fresh buyers in in the morning, And wait for bargain hunting from today's T4 & tomorrow T5.
Anyway, Asiabio-pr still trades at discounted price over the mother. Gd for trade pending the new shares listing... since today is no manipulated pumping up . Bad for contra players of course.
re:Venfx, I don't know if I'm seeing correctly or not, the chart shows me it's a buy... it looks really good... and potential multibagger... need advise...
been hold this stock since last week, now stuck at 0.205 hmmm.... what i analysis on the chart this stock is very potential to growth but still cannot break the resistance
Share price will drop after the last Acceptance and Payment date on 24/11, they push up to 0.21 is to attract market to subscribe for their ICPS. After That, the share price will drop to 0.10 or below.
This book is the result of the author's many years of experience and observation throughout his 26 years in the stockbroking industry. It was written for general public to learn to invest based on facts and not on fantasies or hearsay....
lingling66
406 posts
Posted by lingling66 > 2017-11-16 09:16 | Report Abuse
high profit and potential company..sure hit 0.23